These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 6762869

  • 1. [Effect of probucol on low-density lipoproteins in patients resistant to diet therapy].
    Bertolami MC, Bertolami V.
    Arq Bras Cardiol; 1982 Jun; 38(6):483-7. PubMed ID: 6762869
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia.
    Mellies MJ, Gartside PS, Glatfelter L, Vink P, Guy G, Schonfeld G, Glueck CJ.
    Metabolism; 1980 Oct; 29(10):956-64. PubMed ID: 6999291
    [No Abstract] [Full Text] [Related]

  • 5. Probucol in hypercholesterolemia. A double blind study.
    Riesen WF, Keller M, Mordasini R.
    Atherosclerosis; 1980 Jun; 36(2):201-7. PubMed ID: 7406949
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF.
    JAMA; 1977 Dec 05; 238(23):2537-8. PubMed ID: 199758
    [Abstract] [Full Text] [Related]

  • 8. Diet and drug synergism in treatment of hypercholesterolemia.
    Nutr Rev; 1978 Jan 05; 36(1):8-10. PubMed ID: 203877
    [No Abstract] [Full Text] [Related]

  • 9. [Action of probucol in the control of hypercholesterolemia].
    Quintão EC, Maranhão RC.
    Arq Bras Cardiol; 1980 Apr 05; 34(4):331-3. PubMed ID: 7002123
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G, Witztum J, Basich P.
    Artery; 1982 Apr 05; 10(2):99-104. PubMed ID: 7092583
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [How do changes in the plasma concentration of HDL induced by probucol operate?].
    Med Clin (Barc); 1988 Apr 02; 90(13):556-7. PubMed ID: 3393042
    [No Abstract] [Full Text] [Related]

  • 15. [The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].
    Forti N, Dereviacki BE, Giannini SD.
    Arq Bras Cardiol; 1988 Jul 02; 51(1):49-53. PubMed ID: 3073736
    [No Abstract] [Full Text] [Related]

  • 16. Probucol: a weak hypocholesterolemic agent.
    Mishkel MA, Crowther SM.
    Can Med Assoc J; 1981 Jul 15; 125(2):135. PubMed ID: 7272863
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P, Whiting C, Hammett F, Glick I, Miller NE, Lewis B.
    Artery; 1982 Jul 15; 10(2):88-94. PubMed ID: 7092581
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.